Zentiva Revenue and Competitors

Prague 10,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Zentiva's estimated annual revenue is currently $842.4M per year.(i)
  • Zentiva's estimated revenue per employee is $201,000

Employee Data

  • Zentiva has 4191 Employees.(i)
  • Zentiva grew their employee count by 7% last year.

Zentiva's People

NameTitleEmail/Phone
1
Client Manager CSS - Client Front Office CFO (Multichannel)Reveal Email/Phone
2
Portfolio und Innovation ManagerReveal Email/Phone
3
Sr.Manager - Quality AssuranceReveal Email/Phone
4
General ManagerReveal Email/Phone
5
Consulente tecnico commercialeReveal Email/Phone
6
Retail SpecialistReveal Email/Phone
7
Directeur de la Stratégie Commerciale OfficinaleReveal Email/Phone
8
Sr. ExecutiveReveal Email/Phone
9
Finance AnalystReveal Email/Phone
10
Assoc. Dir, Account Management GHH / Commercial Lead SwitzerlandReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Zentiva?

Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people's daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.

keywords:N/A

N/A

Total Funding

4191

Number of Employees

$842.4M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zentiva News

2022-04-06 - Declining Stock and Decent Financials: Is The Market Wrong ...

In this article, we decided to focus on Zentiva's ROE. Return on equity or ROE is an important factor to be considered by a shareholder because...